AbCellera (ABCL), Everest to Co-Develop New Antibody Therapies

Published on September 23, 2021

AbCellera (ABCL) partners with China-based Everest Medicines to expand the latter???s pipeline across multiple indications.

Continue reading on website
Other news

NRG Energy (NRG) to Redeem $500M of 6.625% Senior Notes

September 23, 2021
NRG Energy (NRG) fixes the redemption price of $500 million of its 6.625% senior notes due 2027. The same is subject to fund availability under its li...

ViacomCBS's (VIAC) BET, BET+ Unveil 2021 Fall Program Lineup

September 23, 2021
ViacomCBS (VIAC) attempts to boost subscriber growth with a chock-a-block schedule of BET and BET+, for the fall of 2021.